Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Jaarsveld

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
International Journal of Sports Medicine|June 22, 1999
The effects of B-sitosterol (BSS) and B-sitosterol glucoside (BSSG) mixture on selected immune parameters of marathon runners: inhibition of post marathon immune suppression and inflammationP J Bouic, A Clark, J Lamprecht, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 1, 1995
A phase I trial of hypoxoside as an oral prodrug for cancer therapy--absence of toxicityB J Smit, C F Albrecht, R W Liebenberg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2009
Erythrocyte membrane fatty acids in patients with multiple sclerosisG M Hon, M S Hassan, S J van Rensburg, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 1997
Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosisD P Parkin, S Vandenplas, F J Botha, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
International Journal of Sports Medicine|June 22, 1999
The effects of B-sitosterol (BSS) and B-sitosterol glucoside (BSSG) mixture on selected immune parameters of marathon runners: inhibition of post marathon immune suppression and inflammationP J Bouic, A Clark, J Lamprecht, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 1, 1995
A phase I trial of hypoxoside as an oral prodrug for cancer therapy--absence of toxicityB J Smit, C F Albrecht, R W Liebenberg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2009
Erythrocyte membrane fatty acids in patients with multiple sclerosisG M Hon, M S Hassan, S J van Rensburg, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 1997
Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosisD P Parkin, S Vandenplas, F J Botha, et al.
Pageof 5